Arcellx (ACLX) Total Current Liabilities (2021 - 2025)
Arcellx's (ACLX) quarterly Total Current Liabilities came in at $104.2 million in Q4 2025, down 16.91% year-on-year from $125.4 million in Q4 2024, and down 11.99% quarter-over-quarter from $118.4 million in Q3 2025.
Arcellx (ACLX) Total Current Liabilities (2021 - 2025) Analysis & Trends
Arcellx's Total Current Liabilities history runs 5 years deep, the most recent figure standing at $104.2 million for Q4 2025.
- On a quarterly basis, Total Current Liabilities fell 16.91% year-over-year to $104.2 million in Q4 2025; TTM through Dec 2025 was $104.2 million, a 16.91% decrease from a year earlier, with the FY2025 full-year figure at $104.2 million, down 16.91% from the prior year.
- Total Current Liabilities eased to $104.2 million in Q4 2025 per ACLX's latest filing, from $118.4 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $173.1 million in Q3 2023 and bottomed at $14.4 million in Q1 2022.
- The 5-year median for Total Current Liabilities is $112.5 million (2025), against an average of $99.0 million.
- Across the five-year window, Total Current Liabilities jumped 1051.18% in 2023 and plunged 43.45% in 2024, its largest moves.
- Year by year, Total Current Liabilities stood at $14.8 million in 2021, then surged by 281.9% to $56.7 million in 2022, then soared by 108.56% to $118.2 million in 2023, then climbed by 6.06% to $125.4 million in 2024, then decreased by 16.91% to $104.2 million in 2025.
- Per Business Quant, the three latest ACLX Total Current Liabilities figures stand at $104.2 million (Q4 2025), $118.4 million (Q3 2025), and $121.8 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 66.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.81 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 6.38 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 289.60 Mn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 104.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 104.20 Mn |
| Sep 30, 2025 | 118.39 Mn |
| Jun 30, 2025 | 121.85 Mn |
| Mar 31, 2025 | 112.46 Mn |
| Dec 31, 2024 | 125.41 Mn |
| Sep 30, 2024 | 137.02 Mn |
| Jun 30, 2024 | 88.29 Mn |
| Mar 31, 2024 | 107.90 Mn |
| Dec 31, 2023 | 118.24 Mn |
| Sep 30, 2023 | 173.15 Mn |
| Jun 30, 2023 | 156.11 Mn |
| Mar 31, 2023 | 166.06 Mn |
| Dec 31, 2022 | 56.69 Mn |
| Sep 30, 2022 | 44.78 Mn |
| Jun 30, 2022 | 23.73 Mn |
| Mar 31, 2022 | 14.43 Mn |
| Dec 31, 2021 | 14.85 Mn |